208 related articles for article (PubMed ID: 15362513)
1. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
Machackova J; Liu X; Lukas A; Dhalla NS
Mol Cell Biochem; 2004 Jun; 261(1-2):271-8. PubMed ID: 15362513
[TBL] [Abstract][Full Text] [Related]
2. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
Wang J; Guo X; Dhalla NS
Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
[TBL] [Abstract][Full Text] [Related]
3. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
6. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan.
Liu X; Sentex E; Golfman L; Takeda S; Osada M; Dhalla NS
Clin Exp Hypertens; 1999; 21(1-2):145-56. PubMed ID: 10052650
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes.
Liu X; Suzuki H; Sethi R; Tappia PS; Takeda N; Dhalla NS
Ann N Y Acad Sci; 2006 Nov; 1084():141-54. PubMed ID: 17151298
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
[TBL] [Abstract][Full Text] [Related]
9. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Richer C; Bruneval P; Ménard J; Giudicelli JF
Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Mohabir R; Young SD; Strosberg AM
J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
16. Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster.
Crespo MJ; Cruz N; Altieri PI; Escobales N
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):199-206. PubMed ID: 18593848
[TBL] [Abstract][Full Text] [Related]
17. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
[TBL] [Abstract][Full Text] [Related]
18. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade.
Kasper SO; Basso N; Kurnjek ML; Paglia N; Ferrario CM; Ferder LF; Diz DI
Am J Nephrol; 2005; 25(4):335-41. PubMed ID: 15976496
[TBL] [Abstract][Full Text] [Related]
19. Impact of early life AT
Poletto Bonetto JH; Fernandes RO; Dartora DR; Flahault A; Sonea A; He Y; Cloutier A; Belló-Klein A; Nuyt AM
Eur J Pharmacol; 2019 Oct; 860():172585. PubMed ID: 31376367
[TBL] [Abstract][Full Text] [Related]
20. Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction.
Wang J; Liu X; Ren B; Rupp H; Takeda N; Dhalla NS
J Mol Cell Cardiol; 2002 Jul; 34(7):847-57. PubMed ID: 12099723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
